Target: Superbugs. Ohio drug startup focused on MRSA infection
An Ohio startup is developing a new antibacterial drug that would keep so-called “superbugs” such as MRSA from replicating in the body. Promiliad Biopharma is hoping its early development efforts yield a new drug capable of beating bacteria that have grown resistant to most antibiotics on the market today. The most well-known example is a […]